Hypogonadism Completed Phase 1 Trials for Finasteride (DB01216)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00663793ORAL T-6: Oral Androgens in Man-6Treatment